Bank of America’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.9K Sell
14,908
-16,842
-53% -$5.54K ﹤0.01% 6264
2025
Q1
$9.87K Sell
31,750
-24,983
-44% -$7.77K ﹤0.01% 6076
2024
Q4
$52.9K Buy
56,733
+18,841
+50% +$17.6K ﹤0.01% 5725
2024
Q3
$44.7K Buy
37,892
+8,358
+28% +$9.86K ﹤0.01% 5687
2024
Q2
$22.7K Buy
29,534
+10,946
+59% +$8.42K ﹤0.01% 5837
2024
Q1
$56.7K Sell
18,588
-35,720
-66% -$109K ﹤0.01% 5606
2023
Q4
$175K Buy
54,308
+14,612
+37% +$47.1K ﹤0.01% 5232
2023
Q3
$152K Sell
39,696
-12,715
-24% -$48.8K ﹤0.01% 5179
2023
Q2
$172K Buy
52,411
+39,299
+300% +$129K ﹤0.01% 5109
2023
Q1
$33.8K Buy
13,112
+9,675
+281% +$25K ﹤0.01% 5804
2022
Q4
$6.39K Sell
3,437
-8,314
-71% -$15.5K ﹤0.01% 6205
2022
Q3
$22K Sell
11,751
-4,556
-28% -$8.53K ﹤0.01% 6134
2022
Q2
$35K Sell
16,307
-25,291
-61% -$54.3K ﹤0.01% 6180
2022
Q1
$131K Buy
41,598
+39,875
+2,314% +$126K ﹤0.01% 5949
2021
Q4
$6K Sell
1,723
-31,949
-95% -$111K ﹤0.01% 6917
2021
Q3
$114K Sell
33,672
-35,430
-51% -$120K ﹤0.01% 5786
2021
Q2
$270K Buy
69,102
+46,678
+208% +$182K ﹤0.01% 5114
2021
Q1
$90K Buy
22,424
+7,025
+46% +$28.2K ﹤0.01% 5760
2020
Q4
$36K Sell
15,399
-7,012
-31% -$16.4K ﹤0.01% 5675
2020
Q3
$128K Buy
22,411
+1,524
+7% +$8.7K ﹤0.01% 4938
2020
Q2
$154K Sell
20,887
-27,303
-57% -$201K ﹤0.01% 4871
2020
Q1
$144K Buy
+48,190
New +$144K ﹤0.01% 4729
2019
Q4
Sell
-3,007
Closed -$10K 6367
2019
Q3
$10K Sell
3,007
-6,190
-67% -$20.6K ﹤0.01% 5876
2019
Q2
$17K Sell
9,197
-19,637
-68% -$36.3K ﹤0.01% 5822
2019
Q1
$51K Buy
28,834
+3,989
+16% +$7.06K ﹤0.01% 5426
2018
Q4
$60K Buy
24,845
+20,525
+475% +$49.6K ﹤0.01% 5397
2018
Q3
$24K Buy
4,320
+1,331
+45% +$7.39K ﹤0.01% 5709
2018
Q2
$23K Buy
2,989
+2,070
+225% +$15.9K ﹤0.01% 5729
2018
Q1
$6K Buy
919
+299
+48% +$1.95K ﹤0.01% 5974
2017
Q4
$6K Buy
620
+383
+162% +$3.71K ﹤0.01% 5879
2017
Q3
$2K Buy
+237
New +$2K ﹤0.01% 6050